According to Marksans Pharma
's latest financial reports the company has A$0.44 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-03-31 | $A$0.38 B | 19.39% |
2023-03-31 | $A$0.32 B | 49.17% |
2022-03-31 | $A$0.21 B | 32.04% |
2021-03-31 | $A$0.16 B | 15.98% |
2020-03-31 | $A$0.14 B | 25.49% |
2019-03-31 | $A$0.11 B | 16.51% |
2018-03-31 | $A$96.04 M | 8.33% |
2017-03-31 | $A$88.65 M | -0.61% |
2016-03-31 | $A$89.2 M | 9.1% |
2015-03-31 | $A$81.76 M | 205.48% |
2014-03-31 | $A$26.76 M | 61.83% |
2013-03-31 | $A$16.53 M | -153.73% |
2012-03-31 | $-A$30.78 Million | 125.82% |
2011-03-31 | $-A$13.64 Million | -134.55% |
2010-03-31 | $A$39.45 M | -7.67% |
2009-03-31 | $A$42.73 M | 10.99% |
2008-03-31 | $A$38.5 M | 6.27% |
2007-03-31 | $A$36.23 M | -4.16% |
2006-03-31 | $A$37.8 M | 24.19% |
2005-03-31 | $A$30.44 M |